These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3043159)

  • 1. [Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].
    Biesenbach G; Grafinger P; Kaiser W; Stuby U; Zazgornik J
    Med Klin (Munich); 1988 May; 83(12):398-401. PubMed ID: 3043159
    [No Abstract]   [Full Text] [Related]  

  • 2. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.
    O'Connell MA; Gilbertson HR; Donath SM; Cameron FJ
    Diabetes Care; 2008 Aug; 31(8):1491-5. PubMed ID: 18509207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin therapy in children and adolescents.
    Tamborlane WV; Sikes KA
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):145-60. PubMed ID: 22575411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
    Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF
    Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous subcutaneous insulin infusion in the treatment of insulin-dependent diabetes mellitus].
    Gröbe H; Seibold H; Ullrich K; Müller-Limmroth S; Ziegler R
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):81-4. PubMed ID: 3367913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
    Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
    J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart.
    Ihlo CA; Lauritzen T; Sturis J; Skyggebjerg O; Christiansen JS; Laursen T
    Diabet Med; 2011 Feb; 28(2):230-6. PubMed ID: 21219436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
    Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
    Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower dose basal insulin infusion has positive effect on glycaemic control for children with type I diabetes on continuous subcutaneous insulin infusion therapy.
    Schulten RJ; Piet J; Bruijning PC; de Waal WJ
    Pediatr Diabetes; 2017 Feb; 18(1):45-50. PubMed ID: 26880282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
    Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical usefulness of a bolus calculator in maintaining normoglycaemia in active professional patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Klupa T; Benbenek-Klupa T; Malecki M; Szalecki M; Sieradzki J
    J Int Med Res; 2008; 36(5):1112-6. PubMed ID: 18831908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
    Murata T; Aoki Y; Kato Y; Tanaka T; Araki R; Kato K; Hida K; Kawamura T; Yoshida K; Imamura Y; Toyonaga T; Yamada K; Sakane N;
    J Diabetes Sci Technol; 2017 Sep; 11(5):1055-1056. PubMed ID: 28859515
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
    Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
    Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy.
    Burdick J; Chase HP; Slover RH; Knievel K; Scrimgeour L; Maniatis AK; Klingensmith GJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):e221-4. PubMed ID: 14993580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.